Experts discuss next-generation pathology and precision care for non-small cell lung cancer in new CME podcast
The CME podcast released on May 6, 2026 brings together Sanja Dacic, Isabel Preeshagul, and Soo-Ryum (Stewart) Yang to review recent advances in pathology for non-small cell lung cancer.
The experts present case studies of patients whose tumors carry actionable alterations and explain how tissue and liquid biopsy results can guide targeted treatment selection.
Listeners are taught to interpret molecular testing, assess emerging and established trial data on targeted therapies, and learn strategies to overcome barriers to biomarker testing while fostering collaboration between pathology and oncology teams.
The activity is funded by educational grants from Lilly, Nuvation Bio, and Revolution Medicines, and the speakers disclose advisory roles with AstraZeneca and other companies.
This writeup was produced by pharmadog from original reporting by onclive.
Original headline: “Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer”
read at onclive ↗
comments(0)
5-min edit window · permanent after that